Is Tarsus Pharmaceuticals, Inc. (TARS) a Buy, Sell, or Hold?
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$56.11 USD
-$3.2 (-5.4%)
- Volume
- 2.08M
- Average Volume
- 881.37K
- Market Capitalization
- $2.41B
- P/E Ratio
- -49.22
- Dividend Yield
- 0.00%
- Price Target
- $68.00
- Year High
- $85.25
- Year Low
- $38.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.74
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-17.5% DOWNSIDE
$68.00 Price Target
UPSIDE/DOWNSIDE HIGH
-17.5% DOWNSIDE
$68.00 Price Target High
UPSIDE/DOWNSIDE LOW
-17.5% DOWNSIDE
$68.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Andrea Tan | $51 | $67.245 | 2025-11-06 09:22 AM | -24.2% |
| Guggenheim | Eddie Hickman | $84 | $47.36 | 2025-05-02 07:51 AM | 77.4% |
| Barclays | Balaji Prasad | $62 | $48.78 | 2025-01-27 05:40 AM | 27.1% |
| Oppenheimer | Francois Brisebois | $72 | $47.143 | 2025-01-22 08:34 AM | 52.7% |
| Oppenheimer | Francois Brisebois | $63 | $34.584 | 2024-09-23 03:33 AM | 82.2% |